The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Recent advances in ocular drug delivery
Abstract
Amongst the various routes of drug delivery, the field of ocular drug delivery is one of the most interesting and challenging endeavors facing the pharmaceutical scientist. Recent research has focused on the characteristic advantages and limitations of the various drug delivery systems, and further research will be required before the ideal system can be developed. Administration of drugs to the ocular region with conventional delivery systems leads to short contact time of the formulations on the epithelium and fast elimination of drugs. This transient residence time involves poor bioavailability of drugs which can be explained by the tear production, non-productive absorption and impermeability of corneal epithelium. Anatomy of the eye is shortly presented and is connected with ophthalmic delivery and bioavailability of drugs. In the present update on ocular dosage forms, chemical delivery systems such as prodrugs, the use of cyclodextrins to increase solubility of various drugs, the concept of penetration enhancers and other ocular drug delivery systems such as polymeric gels, bioadhesive hydrogels, in-situ forming gels with temperature-, pH-, or osmotically induced gelation, combination of polymers and colloidal systems such as liposomes, niosomes, cubosomes, microemulsions, nanoemulsions and nanoparticles are discussed. Novel ophthalmic delivery systems propose the use of many excipients to increase the viscosity or the bioadhesion of the product. New formulations like gels or colloidal systems have been tested with numerous active substances by in vitro and in vivo studies. Sustained drug release and increase in drug bioavailability have been obtained, offering the promise of innovation in drug delivery systems for ocular administration. Combining different properties of pharmaceutical formulations appears to offer a genuine synergy in bioavailability and sustained release. Promising results are obtained with colloidal systems which present very comfortable conditions of use and prolonged action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery
Nanjawade, B. K., Manvi, F. V., & Manjappa, A. S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.009 · Cited by 213
RetractedDrug Development and Industrial Pharmacy
Rhodes, C. T. (1995) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049509070870 · Cited by 1,263
The use of mucoadhesive polymers in ocular drug delivery
LUDWIG, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.005 · Cited by 922
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
MOTWANI, S., CHOPRA, S., TALEGAONKAR, S., KOHLI, K., AHMAD, F., & KHAR, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.09.009 · Cited by 557
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.
Escobar‐Chávez, J. J., López-Cervantes, M., Naik, A., Kalia, Y. N., Quintanar‐Guerrero, D., & Ganem-Quintanar, A. (2006) · PubMed · Cited by 540
de Campos, A. M., Diebold, Y., Carvalho, E. L. S., Sánchez, A., & José Alonso, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026432.75781.cb · Cited by 404
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Guinedi, A. S., Mortada, N. D., Mansour, S., & Hathout, R. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.023 · Cited by 355
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
Hathout, R. M., Mansour, S., Mortada, N. D., & Guinedi, A. S. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801001 · Cited by 346
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
Abdelbary, G., & El-gendy, N. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9105-1 · Cited by 333
Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system
Srividya, B., Cardoza, R. M., & Amin, P. D. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00279-6 · Cited by 330
In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate
El-Kamel, A. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00234-x · Cited by 320
Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
Ammar, H. O., Salama, H. A., Ghorab, M., & Mahmoud, A. A. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9268-4 · Cited by 319
Ocular Preparations: The Formulation Approach
Pal Kaur, I., & Kanwar, M. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003445 · Cited by 310
Ophthalmic drug delivery systems
Shell, J. W. (1984) · Survey of Ophthalmology · doi:10.1016/0039-6257(84)90168-1 · Cited by 291
de Salamanca, A. E., Diebold, Y., Calonge, M., Garci´a-Vazquez, C., Callejo, S., Vila, A., & Alonso, M. J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0495 · Cited by 286
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 285
Recent Advances in Ophthalmic Drug Delivery
Kompella, U. B., Kadam, R. S., & Lee, V. H. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.40 · Cited by 285
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin
Liu, Z., Li, J., Nie, S., Liu, H., Ding, P., & Pan, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.029 · Cited by 276
Garg, G., Saraf, S., & Saraf, S. (2007) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.30.350 · Cited by 266
Aggarwal, D., & Kaur, I. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.026 · Cited by 223
Rheological evaluation of Gelrite® in situ gels for ophthalmic use
Carlfors, J., Edsman, K., Petersson, R., & Jörnving, K. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)00074-2 · Cited by 209
Miyazaki, S., Suzuki, S., Kawasaki, N., Endo, K., Takahashi, A., & Attwood, D. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00825-0 · Cited by 198
Gan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 196
New vehicle based on a microemulsion for topical ocular administration of dexamethasone
Fialho, S. L., & Da Silva‐Cunha, A. (2004) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2004.00914.x · Cited by 193
Sustained Ocular Drug Delivery from a Temperature and pH Triggered Novel In Situ Gel System
Gupta, H., Jain, S., Mathur, R., Mishra, P., Mishra, A. K., & Velpandian, T. (2007) · Drug Delivery · doi:10.1080/10717540701606426 · Cited by 187
Han, S., Shen, J.-Q., Gan, Y., Geng, H.-M., Zhang, X.-X., Zhu, C.-L., & Gan, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.98 · Cited by 177
Giannavola, C., Bucolo, C., Maltese, A., Paolino, D., Vandelli, M. A., Puglisi, G., Lee, V. H. L., & Fresta, M. (2003) · Pharmaceutical Research · doi:10.1023/a:1023290514575 · Cited by 176
Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye
Loftsson, T., & Stefánsson, E. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800205.x · Cited by 173
Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye
Johnson, M. E., Murphy, P. J., & Boulton, M. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0028-1 · Cited by 172
Biopharmaceutics of Ocular Drug Delivery
Edman, P. (2019) · CRC Press eBooks · doi:10.1201/9780429284755 · Cited by 160
Cationic Vectors in Ocular Drug Delivery
Rabinovich‐Guilatt, L., Couvreur, P., Lambert, G., & Dubernet, C. (2004) · Journal of drug targeting · doi:10.1080/10611860400015910 · Cited by 139
Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration
Vega, E., Egea, M. A., Valls, O., Espina, M., & García, M. L. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20685 · Cited by 137
Gan, L., Gan, Y., Zhu, C., et al. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.004 · Cited by 133
Zhang, J., & Wang, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.001 · Cited by 131
Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations
Budai, L., HAJDU, M., Budai, M., Gróf, P., Béni, S., Noszál, B., Klebovich, I., & Antal, I. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.013 · Cited by 128
Ciprofloxacin as Ocular Liposomal Hydrogel
Hosny, K. M. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-009-9373-4 · Cited by 128
Ibrahim, H. K., El-Leithy, I. S., & Makky, A. A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900279c · Cited by 124
Sigurðsson, H. H., Konrádsdóttir, F., Loftsson, Þ., & Stefánsson, E. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00885.x · Cited by 122
Nanoceria have no genotoxic effect on human lens epithelial cells
Pierscionek, B. K., Li, Y., Yasseen, A. A., Colhoun, L. M., Schachar, R. A., & Chen, W. (2009) · Nanotechnology · doi:10.1088/0957-4484/21/3/035102 · Cited by 118
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Shen, Y., & Tu, J. (2007) · The AAPS Journal · doi:10.1208/aapsj0903044 · Cited by 115
Poly(ε-Caprolactone) Nanocapsules in Carteolol Ophthalmic Delivery
Marchal‐Heussler, L., Sirbat, D., Hoffman, M., & Maincent, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018936205485 · Cited by 110
Aggarwal, D., Pal, D., Mitra, A. K., & Kaur, I. P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.019 · Cited by 101
Yenice, İ., Mocan, M. C., Palaska, E., Bochot, A., Bilensoy, E., Vural, İ., Irkec, M. T., & Hıncal, A. A. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.04.002 · Cited by 99
Liposomes as an ocular delivery system of fluconazole: in‐vitro studies
HABIB, F. S., Fouad, E. A., Abdel‐Rhaman, M. S., & Fathalla, D. (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01584.x · Cited by 92
Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution
Klang, S. H., Abdulrazik, M., & Benita, S. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102035 · Cited by 92
Balasubramaniam, J., & Pandit, J. K. (2003) · Drug Delivery · doi:10.1080/713840402 · Cited by 87
Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment
Mehanna, M. M., Elmaradny, H. A., & Samaha, M. W. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903099751 · Cited by 84
Kaur, I. P., Aggarwal, D., Singh, H., & Kakkar, S. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1383-0 · Cited by 82
Hosny, K. M. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9335-x · Cited by 79
Saari, K. M., Nelimarkka, L., Ahola, V., et al. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0124-2 · Cited by 49
Tirucherai, G., Dias, C. S., & Mitra, A. K. (2002) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076802321021081 · Cited by 47
Pietzyk, B., & Henschke, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00425-1 · Cited by 47
Nanoceria Particles Prevent ROI-Induced Blindness
Chen, J., Patil, S. D., Seal, S., & McGinnis, J. F. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_5 · Cited by 41
A water-soluble prodrug of cyclosporine A for ocular application: A stability study
Lallemand, F., Perrottet, P., Felt-Baeyens, O., Kloeti, W., Philippoz, F., Marfurt, J., Besseghir, K., & Gurny, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.003 · Cited by 39
Sakai, T., Ishihara, T., Higaki, M., Akiyama, G., & Tsuneoka, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5676 · Cited by 37
Klang, S., Siganos, C. S., Benita, S., & Frucht‐Pery, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00107-2 · Cited by 37
Zhang, J., Guan, P., Wang, T., Chang, D., Jiang, T., & Wang, S. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.09.0006 · Cited by 27
Cited by
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 543
A comprehensive insight on ocular pharmacokinetics
Agrahari, V., Mandal, A., Agrahari, V., Trinh, H. M., Joseph, M., Ray, A., Hadji, H., Mitra, R., Pal, D., & Mitra, A. K. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0339-2 · Cited by 462
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration
Silva, M., Calado, R., Marto, J., Bettencourt, A., Almeida, A., & Gonçalves, L. (2017) · Marine Drugs · doi:10.3390/md15120370 · Cited by 255
Metadata
- Authors
- Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V.
- Venue
- Drug Development and Industrial Pharmacy
- Publisher
- Informa UK Limited
- Published
- 2012-11-16
- Volume
- 39
- Issue
- 11
- Pages
- 1599-1617
- ISSN
- 0363-9045 (ISSN-L)
- 1520-5762
- OpenAlex
- W2114018039
- Cited by
- 335
- References
- 62
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.